"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","7/35","23/2914",4.09595210316599e-09,1.70801202702022e-06,1.30639314448347e-06,"MAPK1/DUSP2/DUSP10/DUSP9/DUSP7/MAP2K1/DUSP8",7
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","7/35","34/2914",8.18626106909757e-08,1.70683543290684e-05,1.30549321259819e-05,"MAPK1/DUSP2/DUSP10/DUSP9/DUSP7/MAP2K1/DUSP8",7
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/35","44/2914",9.76700095935073e-06,0.00135761313334975,0.0010383864177836,"TP53/MAPK1/MAPK9/MAPKAPK2/E2F1/TFDP1",6
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","16/35","481/2914",4.50138175822279e-05,0.00469269048294725,0.00358925966510922,"TP53/PARP1/MAPK1/SMAD3/GSK3B/NR0B2/CSNK2A1/CTNNB1/TWIST1/MED1/CDK5/MAX/SOCS3/LAMTOR3/E2F1/TFDP1",16
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","16/35","499/2914",7.18332844110562e-05,0.00599089591988209,0.00458220740558948,"TP53/PARP1/MAPK1/SMAD3/GSK3B/NR0B2/CSNK2A1/CTNNB1/TWIST1/MED1/CDK5/MAX/SOCS3/LAMTOR3/E2F1/TFDP1",16
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","9/35","171/2914",0.000125409411031051,0.00783068026273838,0.00598938816006495,"MAPK1/DUSP2/DUSP10/DUSP9/LAMTOR3/FGF19/DUSP7/MAP2K1/DUSP8",9
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/35","23/2914",0.000131450268199445,0.00783068026273838,0.00598938816006495,"TP53/MAPK1/E2F1/TFDP1",4
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","9/35","177/2914",0.000163859741731335,0.00854118903774583,0.00653282917692032,"MAPK1/DUSP2/DUSP10/DUSP9/LAMTOR3/FGF19/DUSP7/MAP2K1/DUSP8",9
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","3/35","11/2914",0.000245351496230562,0.00941419370142184,0.00720055709082624,"MAX/E2F1/TFDP1",3
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","9/35","187/2914",0.000249847809641526,0.00941419370142184,0.00720055709082624,"TP53/HIF1A/MAPK1/MAPK9/GSK3B/MAPKAPK2/LAMTOR3/E2F1/TFDP1",9
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","9/35","188/2914",0.000260212065795607,0.00941419370142184,0.00720055709082624,"MAPK1/DUSP2/DUSP10/DUSP9/LAMTOR3/FGF19/DUSP7/MAP2K1/DUSP8",9
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","9/35","189/2914",0.000270933710092933,0.00941419370142184,0.00720055709082624,"TP53/HIF1A/MAPK1/MAPK9/GSK3B/MAPKAPK2/LAMTOR3/E2F1/TFDP1",9
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","9/35","191/2914",0.000293488053041928,0.00941419370142184,0.00720055709082624,"TP53/MAPK1/PLK1/GSK3B/CSNK2A1/CSNK1D/MAX/E2F1/TFDP1",9
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","4/35","30/2914",0.000383204990129462,0.0114140343488561,0.00873015879768623,"MAPK1/MAPK9/MAPKAPK2/DUSP7",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","9/35","202/2914",0.00044749332932204,0.0124403145551527,0.00951512131821602,"MAPK1/DUSP2/DUSP10/DUSP9/LAMTOR3/FGF19/DUSP7/MAP2K1/DUSP8",9
"R-HSA-450294","R-HSA-450294","MAP kinase activation","5/35","60/2914",0.000631784196328508,0.0164658756168117,0.0125941191768117,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","5/35","64/2914",0.000852021320582745,0.0208995818048826,0.0159852916493233,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/35","99/2914",0.000963744088784384,0.0223267380568382,0.017076868941618,"TP53/MAPK1/MAPK9/MAPKAPK2/E2F1/TFDP1",6
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","3/35","18/2914",0.00114526816194124,0.0246576094520323,0.0188596634203352,"MAX/E2F1/TFDP1",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","11/35","332/2914",0.00118261915837085,0.0246576094520323,0.0188596634203352,"TP53/HIF1A/MAPK1/MAPK9/SMAD3/MAPKAPK2/LCK/TWIST1/SOCS3/DUSP7/MAP2K1",11
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/35","19/2914",0.00134884228707327,0.0267841539861693,0.0204861760893836,"MAX/E2F1/TFDP1",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/35","20/2914",0.00157385136326564,0.0298316372037169,0.0228170795727028,"MAPK1/CSNK2A1/MAP2K1",3
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","9/35","249/2914",0.00204364109757933,0.0335234853783575,0.0256408331935942,"TP53/MAPK1/PLK1/GSK3B/CSNK2A1/CSNK1D/MAX/E2F1/TFDP1",9
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","5/35","78/2914",0.00209019333294315,0.0335234853783575,0.0256408331935942,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","5/35","78/2914",0.00209019333294315,0.0335234853783575,0.0256408331935942,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","5/35","78/2914",0.00209019333294315,0.0335234853783575,0.0256408331935942,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/35","23/2914",0.0023853301066914,0.0361885598238109,0.0276792468171519,"TP53/E2F1/TFDP1",3
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/35","49/2914",0.00251932377020696,0.0361885598238109,0.0276792468171519,"TP53/MAPK1/E2F1/TFDP1",4
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","3/35","24/2914",0.0027037489661196,0.0361885598238109,0.0276792468171519,"MAPK1/MAPKAPK2/DUSP7",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","5/35","83/2914",0.00275306680266219,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","5/35","84/2914",0.00290211533487228,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","5/35","84/2914",0.00290211533487228,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","4/35","52/2914",0.00313782681454574,0.0361885598238109,0.0276792468171519,"HIF1A/CSNK1D/MED1/PER2",4
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5/35","86/2914",0.00321772262513343,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","5/35","86/2914",0.00321772262513343,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","5/35","86/2914",0.00321772262513343,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","5/35","87/2914",0.0033845415662557,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","5/35","87/2914",0.0033845415662557,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","5/35","87/2914",0.0033845415662557,0.0361885598238109,0.0276792468171519,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","7/35","172/2914",0.00363167877016403,0.03786025117896,0.0289578596673606,"TP53/MAPK1/GSK3B/CSNK2A1/LCK/LAMTOR3/FGF19",7
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","5/35","89/2914",0.00373686142988577,0.0380066150307894,0.0290698077857609,"MAPK1/MAPKAPK2/CDK5/DUSP7/MAP2K1",5
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","5/35","90/2914",0.00392262306063872,0.0380403213089848,0.0290955884301966,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","5/35","90/2914",0.00392262306063872,0.0380403213089848,0.0290955884301966,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","3/35","29/2914",0.00468458511000016,0.0434104886860015,0.0332030242884222,"TP53/E2F1/TFDP1",3
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/35","29/2914",0.00468458511000016,0.0434104886860015,0.0332030242884222,"TP53/E2F1/TFDP1",3
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","4/35","59/2914",0.00496986778513196,0.0448493597866127,0.0343035618208852,"TP53/MAPK1/CSNK2A1/LAMTOR3",4
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","11/35","397/2914",0.00505747290963235,0.0448493597866127,0.0343035618208852,"MAPK1/SMAD3/GSK3B/CSNK2A1/ROCK2/CTNNB1/MED1/CDK5/E2F1/TFDP1/MAP2K1",11
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/35","30/2914",0.00516251623443024,0.0448493597866127,0.0343035618208852,"TP53/E2F1/TFDP1",3
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/35","10/2914",0.00593807943693264,0.0485525318666845,0.0371359766644085,"E2F1/TFDP1",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/35","10/2914",0.00593807943693264,0.0485525318666845,0.0371359766644085,"E2F1/TFDP1",2
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/35","10/2914",0.00593807943693264,0.0485525318666845,0.0371359766644085,"MAPK1/MAPK9",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/35","32/2914",0.00620420578714807,0.0488142228913348,0.0373361341311989,"MAPK1/GSK3B/MAPKAPK2",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/35","32/2914",0.00620420578714807,0.0488142228913348,0.0373361341311989,"TP53/MAPK1/LAMTOR3",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/35","101/2914",0.00642848334803422,0.0496421769653754,0.0379694045702606,"TP53/MAPK1/CTNNB1/E2F1/TFDP1",5
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/35","33/2914",0.00676885493961992,0.0511746343565558,0.0391415226808946,"MAPK1/MAPKAPK2/MAP2K1",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/35","103/2914",0.00698299923583024,0.0511746343565558,0.0391415226808946,"TP53/MAPK1/CTNNB1/E2F1/TFDP1",5
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/35","11/2914",0.00720313009042199,0.0511746343565558,0.0391415226808946,"E2F1/TFDP1",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/35","11/2914",0.00720313009042199,0.0511746343565558,0.0391415226808946,"TP53/E2F1",2
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","5/35","104/2914",0.00727255858154016,0.0511746343565558,0.0391415226808946,"TP53/HIF1A/SMAD3/E2F1/TFDP1",5
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/35","34/2914",0.00736325674195048,0.0511746343565558,0.0391415226808946,"MAPK1/LAMTOR3/MAP2K1",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","4/35","68/2914",0.00823748716898495,0.0554469777557318,0.0424092749210822,"TP53/PLK1/CSNK1D/E2F1",4
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","7/35","201/2914",0.00855602943616273,0.0554469777557318,0.0424092749210822,"TP53/MAPK1/GSK3B/CSNK2A1/LCK/LAMTOR3/FGF19",7
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/35","12/2914",0.00857886722892212,0.0554469777557318,0.0424092749210822,"MAPK1/MAP2K1",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/35","12/2914",0.00857886722892212,0.0554469777557318,0.0424092749210822,"MAPK1/DUSP7",2
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/35","36/2914",0.00864281427847138,0.0554469777557318,0.0424092749210822,"PARP1/SMAD3/TFDP1",3
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","4/35","70/2914",0.00911804719613492,0.0571970654763962,0.0437478501561228,"MAPK1/MAPKAPK2/DUSP7/MAP2K1",4
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","5/35","110/2914",0.00918993617966078,0.0571970654763962,0.0437478501561228,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-69242","R-HSA-69242","S Phase","4/35","71/2914",0.00958064645503259,0.058751905466891,0.0449370878618402,"GSK3B/MAX/E2F1/TFDP1",4
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","3/35","38/2914",0.0100456251633806,0.0599443757007862,0.0458491627851526,"GSK3B/ROCK2/CDK5",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/35","13/2914",0.0100626050337051,0.0599443757007862,0.0458491627851526,"MAPK1/MAP2K1",2
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/35","39/2914",0.0107940049431202,0.0622917971011489,0.0476446157305267,"MAX/E2F1/TFDP1",3
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/35","40/2914",0.0115740576325508,0.0622917971011489,0.0476446157305267,"MAX/E2F1/TFDP1",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/35","14/2914",0.0116517030548912,0.0622917971011489,0.0476446157305267,"GSK3B/CTNNB1",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/35","14/2914",0.0116517030548912,0.0622917971011489,0.0476446157305267,"GSK3B/CTNNB1",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0622917971011489,0.0476446157305267,"GSK3B/CTNNB1",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0622917971011489,0.0476446157305267,"GSK3B/CTNNB1",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0622917971011489,0.0476446157305267,"GSK3B/CTNNB1",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0622917971011489,0.0476446157305267,"GSK3B/CTNNB1",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/35","15/2914",0.01334356555819,0.0695533354720654,0.0531986890017312,"TP53/TFDP1",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/35","15/2914",0.01334356555819,0.0695533354720654,0.0531986890017312,"E2F1/TFDP1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/35","16/2914",0.0151356408801438,0.0769702713051214,0.0588716198547313,"GSK3B/CTNNB1",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/35","16/2914",0.0151356408801438,0.0769702713051214,0.0588716198547313,"TP53/PLK1",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","5/35","127/2914",0.0164825430732334,0.0828098850787753,0.0633381173264392,"MAPK1/MAPK9/MAPKAPK2/DUSP7/MAP2K1",5
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","9/35","347/2914",0.0181976920125122,0.0903385424906854,0.0690964997467567,"MAPK1/ROCK2/MAPKAPK2/CTNNB1/LCK/CDK5/FGF19/DUSP7/MAP2K1",9
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/35","49/2914",0.0200526401347948,0.0983758933671697,0.0752439623633786,"MAPK1/GSK3B/MAPKAPK2",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/35","20/2914",0.0232565441599844,0.112767196682715,0.0862513204464537,"PARP1/SMAD3",2
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/35","53/2914",0.024678736605622,0.115915989587993,0.0886597118393584,"MAPK1/CSNK2A1/MAP2K1",3
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","3/35","53/2914",0.024678736605622,0.115915989587993,0.0886597118393584,"TP53/SMAD3/CTNNB1",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","4/35","94/2914",0.0247398634852071,0.115915989587993,0.0886597118393584,"TP53/HIF1A/TWIST1/SOCS3",4
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","2/35","21/2914",0.025512907019309,0.118209802522798,0.0904141617175512,"MAPK1/DUSP7",2
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","6/35","194/2914",0.0258005942680471,0.118229096810721,0.0904289191812408,"TP53/CSNK2A1/CDK5/LAMTOR3/E2F1/TFDP1",6
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/35","56/2914",0.0284976878773533,0.127779955321036,0.0977340059630792,"TP53/CSNK2A1/CDK5",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/35","56/2914",0.0284976878773533,0.127779955321036,0.0977340059630792,"PLK1/CSNK2A1/CSNK1D",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","2/35","24/2914",0.0327877522800303,0.143920975797607,0.110079655854284,"SMAD3/TFDP1",2
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","2/35","24/2914",0.0327877522800303,0.143920975797607,0.110079655854284,"MAPK1/SOCS3",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/35","60/2914",0.0340541904173964,0.147922889625566,0.113140566847271,"MAX/E2F1/TFDP1",3
"R-HSA-68886","R-HSA-68886","M Phase","4/35","105/2914",0.0353359009719889,0.148999075714044,0.113963700470416,"MAPK1/PLK1/CSNK2A1/CSNK1D",4
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/35","25/2914",0.0353738812846291,0.148999075714044,0.113963700470416,"PLK1/CSNK1D",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/35","25/2914",0.0353738812846291,0.148999075714044,0.113963700470416,"PLK1/CSNK1D",2
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","7/35","268/2914",0.0367002115188356,0.152513717928514,0.116651916022567,"MAPK1/SMAD3/GSK3B/CTNNB1/LCK/FGF19/MAP2K1",7
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","3/35","62/2914",0.0370303036533544,0.152513717928514,0.116651916022567,"MAPK1/GSK3B/TWIST1",3
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/35","26/2914",0.0380369943994376,0.152513717928514,0.116651916022567,"PLK1/CSNK1D",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/35","26/2914",0.0380369943994376,0.152513717928514,0.116651916022567,"PLK1/CSNK1D",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/35","26/2914",0.0380369943994376,0.152513717928514,0.116651916022567,"GSK3B/TWIST1",2
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/35","63/2914",0.0385674762752729,0.153167977207512,0.117152333948949,"PARP1/SMAD3/TFDP1",3
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/35","27/2914",0.0407749845173355,0.157436745775268,0.12041735193716,"PLK1/CSNK1D",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/35","27/2914",0.0407749845173355,0.157436745775268,0.12041735193716,"PLK1/CSNK1D",2
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","2/35","27/2914",0.0407749845173355,0.157436745775268,0.12041735193716,"E2F1/TFDP1",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/35","66/2914",0.0433739169487649,0.16374117911823,0.125239372138896,"TP53/PLK1/CSNK1D",3
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/35","28/2914",0.0435857814919029,0.16374117911823,0.125239372138896,"PLK1/CSNK1D",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/35","28/2914",0.0435857814919029,0.16374117911823,0.125239372138896,"MAPK1/FGF19",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/35","30/2914",0.0494176969771115,0.180764733679434,0.138260038634024,"MAPK1/MAPK9",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/35","30/2914",0.0494176969771115,0.180764733679434,0.138260038634024,"TP53/CSNK2A1",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/35","30/2914",0.0494176969771115,0.180764733679434,0.138260038634024,"GSK3B/CTNNB1",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/35","31/2914",0.0524348551457801,0.188494263756813,0.144172060881773,"TP53/CSNK2A1",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/35","31/2914",0.0524348551457801,0.188494263756813,0.144172060881773,"GSK3B/CTNNB1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/35","32/2914",0.0555168984363555,0.197867920068036,0.151341612471576,"MAPK1/MAP2K1",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","2/35","33/2914",0.058661933500661,0.20730530737098,0.15855990946209,"MAPK1/PLK1",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/35","428/2914",0.0605435073643959,0.21215666026011,0.162270523939955,"MAPK1/MAPK9/PTPRB/MAPKAPK2/CTNNB1/LCK/LAMTOR3/DUSP7/MAP2K1",9
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/35","77/2914",0.0634332982415821,0.220430711389498,0.168599029536837,"MAX/E2F1/TFDP1",3
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/35","35/2914",0.0651335740941201,0.224468598324364,0.171687454984936,"TP53/LAMTOR3",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","4/35","130/2914",0.0680159403429701,0.232480714123103,0.177815616254702,"MAPK1/PLK1/ROCK2/CTNNB1",4
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/35","80/2914",0.0695433746570146,0.233867638967541,0.178876422080436,"PLK1/CSNK1D/MED1",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/35","80/2914",0.0695433746570146,0.233867638967541,0.178876422080436,"TP53/HIF1A/SMAD3",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/35","37/2914",0.0718352973125952,0.237740626820256,0.181838722520604,"GSK3B/CTNNB1",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/35","37/2914",0.0718352973125952,0.237740626820256,0.181838722520604,"PLK1/CSNK1D",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/35","38/2914",0.0752680568764405,0.247139997775399,0.189027942259109,"MAPK1/FGF19",2
"R-HSA-422475","R-HSA-422475","Axon guidance","6/35","254/2914",0.0785375094455729,0.255860479990655,0.195697905937571,"MAPK1/GSK3B/CSNK2A1/ROCK2/CDK5/MAP2K1",6
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","3/35","85/2914",0.0803040607602541,0.259587545248263,0.198548595759747,"ROCK2/MAPKAPK2/CTNNB1",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/35","40/2914",0.0822888819822111,0.260752181201502,0.1994393813052,"E2F1/TFDP1",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/35","40/2914",0.0822888819822111,0.260752181201502,0.1994393813052,"E2F1/TFDP1",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/35","86/2914",0.0825402587975976,0.260752181201502,0.1994393813052,"PARP1/SMAD3/TFDP1",3
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/35","42/2914",0.0895058201397502,0.272437423345079,0.208376976583514,"PLK1/CSNK1D",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/35","42/2914",0.0895058201397502,0.272437423345079,0.208376976583514,"MAPK1/MAP2K1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/35","42/2914",0.0895058201397502,0.272437423345079,0.208376976583514,"MAPK1/MAP2K1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/35","42/2914",0.0895058201397502,0.272437423345079,0.208376976583514,"MAPK1/MAP2K1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/35","42/2914",0.0895058201397502,0.272437423345079,0.208376976583514,"MAPK1/MAP2K1",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","3/35","92/2914",0.0965208115576944,0.289562434673083,0.221475243483388,"ROCK2/MAPKAPK2/CTNNB1",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","3/35","92/2914",0.0965208115576944,0.289562434673083,0.221475243483388,"MAPK1/LCK/FGF19",3
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","3/35","95/2914",0.103859146710963,0.303680368391618,0.232273511605857,"TP53/CSNK2A1/CDK5",3
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/35","46/2914",0.104477559203022,0.303680368391618,0.232273511605857,"NR0B2/MED1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/35","46/2914",0.104477559203022,0.303680368391618,0.232273511605857,"MAPK1/MAP2K1",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","2/35","47/2914",0.108323725598628,0.303680368391618,0.232273511605857,"HIF1A/SOCS3",2
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","2/35","47/2914",0.108323725598628,0.303680368391618,0.232273511605857,"HIF1A/SOCS3",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","3/35","97/2914",0.108874351168282,0.303680368391618,0.232273511605857,"GSK3B/LCK/FGF19",3
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/35","99/2914",0.113984836373009,0.303680368391618,0.232273511605857,"MAPK1/LCK/FGF19",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"MAP2K1",1
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"MAPK1",1
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"LCK",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"TP53",1
"R-HSA-74749","R-HSA-74749","Signal attenuation","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"MAPK1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"CSNK2A1",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/35","10/2914",0.113988288193787,0.303680368391618,0.232273511605857,"MAPK1",1
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/35","49/2914",0.116129787641327,0.303680368391618,0.232273511605857,"MAPK1/MAP2K1",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/35","49/2914",0.116129787641327,0.303680368391618,0.232273511605857,"MED1/FOXA1",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","2/35","51/2914",0.12407822754273,0.303680368391618,0.232273511605857,"HIF1A/SOCS3",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"SOCS3",1
"R-HSA-110373","R-HSA-110373","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"PARP1",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"LCK",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"SOCS3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"TP53",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"ROCK2",1
"R-HSA-5210891","R-HSA-5210891","Uptake and function of anthrax toxins","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"MAP2K1",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"ROCK2",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"TP53",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/35","11/2914",0.124666804004124,0.303680368391618,0.232273511605857,"MAPKAPK2",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/35","52/2914",0.128102464274778,0.303680368391618,0.232273511605857,"MAPK1/FGF19",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/35","52/2914",0.128102464274778,0.303680368391618,0.232273511605857,"MAPK1/FGF19",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/35","53/2914",0.132158296732392,0.303680368391618,0.232273511605857,"CSNK2A1/LAMTOR3",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"MAPK1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CSNK2A1",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"SMAD3",1
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"LCK",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CSNK1D",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CTNNB1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"LCK",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"LCK",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CTNNB1",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CSNK1D",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CSNK1D",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"CSNK1D",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"LCK",1
"R-HSA-9639288","R-HSA-9639288","Amino acids regulate mTORC1","1/35","12/2914",0.13522025280187,0.303680368391618,0.232273511605857,"LAMTOR3",1
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","3/35","108/2914",0.138088009597523,0.303680368391618,0.232273511605857,"GSK3B/CSNK2A1/CTNNB1",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","3/35","108/2914",0.138088009597523,0.303680368391618,0.232273511605857,"MAPK1/MED1/FOXA1",3
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/35","55/2914",0.14035965217538,0.303680368391618,0.232273511605857,"MAPK1/FGF19",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"MED1",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"MAPKAPK2",1
"R-HSA-190322","R-HSA-190322","FGFR4 ligand binding and activation","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"FGF19",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"GSK3B",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/35","13/2914",0.14565005678255,0.303680368391618,0.232273511605857,"TP53",1
"R-HSA-1643685","R-HSA-1643685","Disease","8/35","443/2914",0.150722639507157,0.309687278872761,0.236867967937515,"MAPK1/SMAD3/GSK3B/CTNNB1/LCK/CDK5/FGF19/MAP2K1",8
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"MAPK1",1
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"MED1",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"CTNNB1",1
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"FGF19",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"MAP2K1",1
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"TP53",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"SOCS3",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/35","14/2914",0.155957622453909,0.309687278872761,0.236867967937515,"SMAD3",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/35","59/2914",0.157086803693143,0.310451171279814,0.237452240054988,"MAPK1/CDK5",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/35","61/2914",0.165593832031993,0.310682466883867,0.237629149225828,"CSNK2A1/LAMTOR3",2
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"SMAD3",1
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"LCK",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"PLK1",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"ROCK2",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"GSK3B",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"CDK5",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"CTNNB1",1
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","1/35","15/2914",0.166144340803603,0.310682466883867,0.237629149225828,"SMAD3",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/35","119/2914",0.169724151283933,0.314842937785797,0.240811334466986,"CSNK2A1/MAPKAPK2/MED1",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/35","62/2914",0.169879282977948,0.314842937785797,0.240811334466986,"TP53/CDK5",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/35","16/2914",0.176211587465167,0.318096242307249,0.243299662802212,"MAPK1",1
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/35","16/2914",0.176211587465167,0.318096242307249,0.243299662802212,"LAMTOR3",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/35","16/2914",0.176211587465167,0.318096242307249,0.243299662802212,"TP53",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/35","16/2914",0.176211587465167,0.318096242307249,0.243299662802212,"CSNK2A1",1
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","1/35","16/2914",0.176211587465167,0.318096242307249,0.243299662802212,"MAPK1",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/35","16/2914",0.176211587465167,0.318096242307249,0.243299662802212,"PARP1",1
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","7/35","393/2914",0.183629812475067,0.328936531533474,0.25159098587566,"TP53/HIF1A/PARP1/SMAD3/CSNK1D/SOCS3/PEX14",7
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","3/35","124/2914",0.184778464921452,0.328936531533474,0.25159098587566,"TP53/HIF1A/SMAD3",3
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","1/35","17/2914",0.186160722882254,0.328936531533474,0.25159098587566,"LCK",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/35","17/2914",0.186160722882254,0.328936531533474,0.25159098587566,"PARP1",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/35","17/2914",0.186160722882254,0.328936531533474,0.25159098587566,"SMAD3",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/35","125/2914",0.187833928961827,0.330492609186,0.252781170221779,"MAPK1/PTPRB/LAMTOR3",3
"R-HSA-5663205","R-HSA-5663205","Infectious disease","3/35","126/2914",0.190903447992497,0.33358824310401,0.255148902336274,"CTNNB1/LCK/MAP2K1",3
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"HIF1A",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"LCK",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"LAMTOR3",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"GSK3B",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"PLK1",1
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"MAPK1",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/35","18/2914",0.195993092471181,0.33358824310401,0.255148902336274,"CSNK2A1",1
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"MED1",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"PLK1",1
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"LCK",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"CTNNB1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"GSK3B",1
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"FGF19",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"FGF19",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"CSNK2A1",1
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"MAPK1",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"PEX14",1
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","1/35","19/2914",0.205710026781785,0.335082348312517,0.256291686327635,"SMAD3",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/35","72/2914",0.213659150141778,0.34138956262665,0.261115833587972,"LCK/FGF19",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/35","20/2914",0.215312841656616,0.34138956262665,0.261115833587972,"MED1",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/35","20/2914",0.215312841656616,0.34138956262665,0.261115833587972,"MAPKAPK2",1
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/35","20/2914",0.215312841656616,0.34138956262665,0.261115833587972,"CSNK1D",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/35","20/2914",0.215312841656616,0.34138956262665,0.261115833587972,"MAPK1",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/35","20/2914",0.215312841656616,0.34138956262665,0.261115833587972,"MAPK9",1
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/35","20/2914",0.215312841656616,0.34138956262665,0.261115833587972,"MAP2K1",1
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","3/35","136/2914",0.222296141491098,0.347195494844433,0.265556569324405,"MAPK1/MED1/FOXA1",3
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/35","21/2914",0.224802838388482,0.347195494844433,0.265556569324405,"CTNNB1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/35","21/2914",0.224802838388482,0.347195494844433,0.265556569324405,"LCK",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/35","21/2914",0.224802838388482,0.347195494844433,0.265556569324405,"ROCK2",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/35","21/2914",0.224802838388482,0.347195494844433,0.265556569324405,"MAPKAPK2",1
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","1/35","21/2914",0.224802838388482,0.347195494844433,0.265556569324405,"FGF19",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/35","21/2914",0.224802838388482,0.347195494844433,0.265556569324405,"PARP1",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"CDK5",1
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"CTNNB1",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"SMAD3",1
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"MAPK1",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"CTNNB1",1
"R-HSA-5696400","R-HSA-5696400","Dual Incision in GG-NER","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"PARP1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"TP53",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/35","22/2914",0.23418130387635,0.350012916546373,0.267711507543988,"PEX14",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/35","23/2914",0.243449510779645,0.359994489344368,0.275346031228937,"SOCS3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/35","23/2914",0.243449510779645,0.359994489344368,0.275346031228937,"E2F1",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/35","23/2914",0.243449510779645,0.359994489344368,0.275346031228937,"CSNK1D",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"HIF1A",1
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"LCK",1
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"LCK",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"TP53",1
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"GSK3B",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"TP53",1
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"MAPK1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"SOCS3",1
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","1/35","24/2914",0.252608717670932,0.361985688208862,0.276869023166187,"MAPK1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/35","81/2914",0.253973957659164,0.362695686109148,0.277412073434487,"TP53/PARP1",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/35","82/2914",0.258479245584488,0.366148626010036,0.280053095244329,"SMAD3/MAP2K1",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","1/35","25/2914",0.261660169187028,0.366148626010036,0.280053095244329,"MAPK1",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/35","25/2914",0.261660169187028,0.366148626010036,0.280053095244329,"CTNNB1",1
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","1/35","25/2914",0.261660169187028,0.366148626010036,0.280053095244329,"MAPK1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/35","25/2914",0.261660169187028,0.366148626010036,0.280053095244329,"CSNK2A1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/35","25/2914",0.261660169187028,0.366148626010036,0.280053095244329,"CDK5",1
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/35","26/2914",0.270605096178532,0.374891445536371,0.286740143878633,"MAPK1",1
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/35","26/2914",0.270605096178532,0.374891445536371,0.286740143878633,"FGF19",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/35","26/2914",0.270605096178532,0.374891445536371,0.286740143878633,"CTNNB1",1
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","2/35","86/2914",0.276518337898417,0.38081191670819,0.291268486085023,"CSNK2A1/SOCS3",2
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/35","27/2914",0.279444715857809,0.38081191670819,0.291268486085023,"LAMTOR3",1
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","1/35","27/2914",0.279444715857809,0.38081191670819,0.291268486085023,"MAPK1",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/35","27/2914",0.279444715857809,0.38081191670819,0.291268486085023,"TP53",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/35","27/2914",0.279444715857809,0.38081191670819,0.291268486085023,"PEX14",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/35","87/2914",0.281029268350924,0.381723794470147,0.291965946546648,"MAPK1/MAPK9",2
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/35","28/2914",0.288180231945435,0.386402433187287,0.295544458552942,"LCK",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/35","28/2914",0.288180231945435,0.386402433187287,0.295544458552942,"PLK1",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/35","28/2914",0.288180231945435,0.386402433187287,0.295544458552942,"SMAD3",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/35","28/2914",0.288180231945435,0.386402433187287,0.295544458552942,"MED1",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","4/35","228/2914",0.291397835369999,0.389464414581056,0.297886451137347,"MAPK1/PLK1/ROCK2/CTNNB1",4
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/35","29/2914",0.29681283481512,0.390444643905063,0.298636191097397,"PLK1",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/35","29/2914",0.29681283481512,0.390444643905063,0.298636191097397,"PLK1",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/35","29/2914",0.29681283481512,0.390444643905063,0.298636191097397,"MAP2K1",1
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","1/35","29/2914",0.29681283481512,0.390444643905063,0.298636191097397,"TP53",1
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","1/35","29/2914",0.29681283481512,0.390444643905063,0.298636191097397,"TP53",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/35","30/2914",0.30534370163712,0.395429576343723,0.302448975469262,"CSNK2A1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/35","30/2914",0.30534370163712,0.395429576343723,0.302448975469262,"PLK1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/35","30/2914",0.30534370163712,0.395429576343723,0.302448975469262,"TP53",1
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","1/35","30/2914",0.30534370163712,0.395429576343723,0.302448975469262,"MAPK1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/35","30/2914",0.30534370163712,0.395429576343723,0.302448975469262,"PARP1",1
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","1/35","31/2914",0.313773996520164,0.402596173996642,0.307930432212501,"CTNNB1",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/35","31/2914",0.313773996520164,0.402596173996642,0.307930432212501,"LCK",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/35","31/2914",0.313773996520164,0.402596173996642,0.307930432212501,"MAPKAPK2",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/35","32/2914",0.3221048706519,0.409505277627568,0.313214941615936,"MED1",1
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","1/35","32/2914",0.3221048706519,0.409505277627568,0.313214941615936,"MAPK1",1
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","1/35","32/2914",0.3221048706519,0.409505277627568,0.313214941615936,"MAPK1",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"MAPK1",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"PLK1",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"CTNNB1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"PLK1",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"ROCK2",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"CSNK1D",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"TP53",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/35","34/2914",0.338472897639082,0.418822546930259,0.320341364937192,"TP53",1
"R-HSA-195721","R-HSA-195721","Signaling by WNT","3/35","172/2914",0.341629596977756,0.421477934732912,0.322372369617752,"GSK3B/CSNK2A1/CTNNB1",3
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/35","35/2914",0.346512289508052,0.423740834970257,0.324103175554683,"CTNNB1",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/35","35/2914",0.346512289508052,0.423740834970257,0.324103175554683,"GSK3B",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/35","35/2914",0.346512289508052,0.423740834970257,0.324103175554683,"TP53",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/35","37/2914",0.362307334523854,0.440472765295764,0.336900789813496,"GSK3B",1
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","1/35","37/2914",0.362307334523854,0.440472765295764,0.336900789813496,"MAPK1",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/35","38/2914",0.370065152838649,0.446332976491497,0.341383041466424,"MED1",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/35","38/2914",0.370065152838649,0.446332976491497,0.341383041466424,"PARP1",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","2/35","107/2914",0.370338632772322,0.446332976491497,0.341383041466424,"TP53/PARP1",2
"R-HSA-2990846","R-HSA-2990846","SUMOylation","2/35","109/2914",0.379091744082288,0.453878236031535,0.347154122220258,"TP53/PARP1",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","2/35","109/2914",0.379091744082288,0.453878236031535,0.347154122220258,"MAPKAPK2/CSNK1D",2
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/35","40/2914",0.385306703969217,0.453878236031535,0.347154122220258,"PLK1",1
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/35","40/2914",0.385306703969217,0.453878236031535,0.347154122220258,"HIF1A",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/35","40/2914",0.385306703969217,0.453878236031535,0.347154122220258,"MED1",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/35","40/2914",0.385306703969217,0.453878236031535,0.347154122220258,"CTNNB1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/35","40/2914",0.385306703969217,0.453878236031535,0.347154122220258,"PLK1",1
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","1/35","40/2914",0.385306703969217,0.453878236031535,0.347154122220258,"SMAD3",1
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/35","41/2914",0.392792530469244,0.458808081808612,0.350924772909276,"LCK",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/35","41/2914",0.392792530469244,0.458808081808612,0.350924772909276,"LCK",1
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","1/35","41/2914",0.392792530469244,0.458808081808612,0.350924772909276,"MAPK1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/35","42/2914",0.400189767306548,0.461658746295816,0.353105137265258,"FGF19",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/35","42/2914",0.400189767306548,0.461658746295816,0.353105137265258,"CTNNB1",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/35","42/2914",0.400189767306548,0.461658746295816,0.353105137265258,"PLK1",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/35","42/2914",0.400189767306548,0.461658746295816,0.353105137265258,"SOCS3",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","2/35","114/2914",0.400768503978622,0.461658746295816,0.353105137265258,"TP53/PLK1",2
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/35","43/2914",0.407499432398565,0.466833140962092,0.357062834056579,"LCK",1
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","1/35","43/2914",0.407499432398565,0.466833140962092,0.357062834056579,"MAPK1",1
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","1/35","45/2914",0.421860062410771,0.481960674041895,0.368633306158511,"MAPK1",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/35","46/2914",0.428913006926499,0.486023706218343,0.371740964241217,"FGF19",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/35","46/2914",0.428913006926499,0.486023706218343,0.371740964241217,"PARP1",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/35","46/2914",0.428913006926499,0.486023706218343,0.371740964241217,"TP53",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/35","47/2914",0.435882339129279,0.488610041443305,0.37371915324327,"MED1",1
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","1/35","47/2914",0.435882339129279,0.488610041443305,0.37371915324327,"MAPK1",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/35","47/2914",0.435882339129279,0.488610041443305,0.37371915324327,"PLK1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/35","47/2914",0.435882339129279,0.488610041443305,0.37371915324327,"SOCS3",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/35","48/2914",0.442769021421039,0.494999147272314,0.378605936194652,"MED1",1
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","1/35","49/2914",0.449574005458116,0.498596702861794,0.381357569019623,"LCK",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","1/35","49/2914",0.449574005458116,0.498596702861794,0.381357569019623,"MAPK1",1
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","1/35","49/2914",0.449574005458116,0.498596702861794,0.381357569019623,"SMAD3",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/35","50/2914",0.456298232267529,0.503376621311004,0.385013546023562,"FGF19",1
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","1/35","50/2914",0.456298232267529,0.503376621311004,0.385013546023562,"MAPK1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/35","51/2914",0.462942632362024,0.506685243293869,0.387544184571608,"FGF19",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/35","51/2914",0.462942632362024,0.506685243293869,0.387544184571608,"FGF19",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/35","51/2914",0.462942632362024,0.506685243293869,0.387544184571608,"E2F1",1
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/35","53/2914",0.475995622567807,0.519607786939203,0.397428144497232,"LCK",1
"R-HSA-109582","R-HSA-109582","Hemostasis","4/35","298/2914",0.487667908932882,0.529362777445742,0.404889364044074,"TP53/MAPK1/LCK/CDK5",4
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/35","55/2914",0.488740214188515,0.529362777445742,0.404889364044074,"GSK3B",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/35","55/2914",0.488740214188515,0.529362777445742,0.404889364044074,"PARP1",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/35","56/2914",0.494999078303032,0.534752890291099,0.409012055429012,"PLK1",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/35","57/2914",0.501183484272029,0.53864307459133,0.411987508774891,"CTNNB1",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/35","57/2914",0.501183484272029,0.53864307459133,0.411987508774891,"MAP2K1",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/35","59/2914",0.513332352275554,0.550281724675851,0.420889467567292,"LCK",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/35","60/2914",0.519298505575153,0.55524994057651,0.424689466097898,"PLK1",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/35","61/2914",0.525193583467539,0.558688072209091,0.427319161629066,"PLK1",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/35","61/2914",0.525193583467539,0.558688072209091,0.427319161629066,"ROCK2",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","1/35","62/2914",0.531018408065729,0.56201694457718,0.429865288923099,"MAPK1",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/35","62/2914",0.531018408065729,0.56201694457718,0.429865288923099,"TP53",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/35","63/2914",0.536773792258471,0.565239069120662,0.432329768884414,"PARP1",1
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","1/35","63/2914",0.536773792258471,0.565239069120662,0.432329768884414,"MAPK1",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/35","64/2914",0.542460539810541,0.56978852670276,0.435809475175909,"HIF1A",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","2/35","153/2914",0.556320324881211,0.582878330340364,0.445821365879415,"MAPK1/LCK",2
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/35","68/2914",0.564536925097132,0.590004756304522,0.45127209683269,"ROCK2",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/35","69/2914",0.569892233467336,0.593451453800649,0.453908344065623,"LCK",1
"R-HSA-73894","R-HSA-73894","DNA Repair","2/35","157/2914",0.57068113423036,0.593451453800649,0.453908344065623,"TP53/PARP1",2
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/35","76/2914",0.605628393868229,0.628226468266297,0.480506424043135,"CTNNB1",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","1/35","77/2914",0.61049203242165,0.631700192356894,0.483163342885621,"MAPK1",1
"R-HSA-162906","R-HSA-162906","HIV Infection","1/35","80/2914",0.624735924033736,0.644838812678386,0.493212571605581,"LCK",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","1/35","88/2914",0.660290523793378,0.678180168526696,0.518714100879942,"MAPK1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/35","88/2914",0.660290523793378,0.678180168526696,0.518714100879942,"SOCS3",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","3/35","289/2914",0.689778647784425,0.706726526108366,0.540548119174138,"CSNK2A1/MAPKAPK2/MED1",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","1/35","97/2914",0.69638218256622,0.711743554240475,0.544385452315699,"SOCS3",1
"R-HSA-112316","R-HSA-112316","Neuronal System","1/35","105/2914",0.725314915416779,0.739502004226887,0.565616830192469,"MAPK1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/35","217/2914",0.747537764795844,0.760300604682602,0.58152488506583,"MAPK1/CDK5",2
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/35","115/2914",0.757732994520398,0.768794790060842,0.588021762939379,"SOCS3",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/35","144/2914",0.832115674301812,0.842214165494795,0.644177438205031,"CSNK1D",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/35","160/2914",0.863098104310229,0.871457407983936,0.666544477140307,"CSNK1D",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","1/35","165/2914",0.871585076106159,0.877900909990986,0.671472865650054,"MAPK1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","2/35","296/2914",0.884795678821701,0.889059754382287,0.680007839398796,"LCK/SOCS3",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","3/35","436/2914",0.913345547245641,0.91554108942652,0.700262400848758,"MAPK1/ROCK2/CDK5",3
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","3/35","486/2914",0.947346737909752,0.947346737909752,0.724589326231617,"MAPK1/ROCK2/CDK5",3
